Xiang Guo

Xiang Guo currently serves as Senior Director of Translational Medicine at Exelixis since September 2022. Prior experience includes roles as Director of Clinical Biomarkers at GSK from September 2021 to September 2022, Associate Director of Translational Medicine at Bristol Myers Squibb from October 2019 to September 2021, and Senior Scientist at AstraZeneca from October 2010 to October 2019. Early career experience features positions as Bioinformatics Analyst in Oncogenomics at the National Cancer Institute from April 2008 to October 2010, and Bioinformatics Engineer at The Institute for Genomic Research from June 2006 to April 2008. Xiang Guo holds a Master of Engineering in Computer Science from Cornell University, a PhD in Pharmacology from the Chinese Academy of Sciences, and a Bachelor of Science in Biopharmaceutics from China Pharmaceutical University.